The purpose of this study is to investigate the use of radiolabeled particulate cholesterol
administered intravenously in association with albumin, as a method to study reverse
cholesterol transport (RCT) in people carrying mutations in genes known to affect high
density lipoprotein (HDL) metabolism by analyzing changes in the tracer activity in total
plasma, lipoproteins fractions and feces.